Latest trial over Zantac cancer claims called off

A woman who claimed in a lawsuit that GSK’s discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

See the original article at: Honolulu Star-Advertiser